Agilent Technologies Inc (A)
134.16
+2.10
(+1.59%)
USD |
NYSE |
Nov 22, 15:50
Agilent Technologies Revenue (TTM): 6.497B for July 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| July 31, 2024 | 6.497B |
| April 30, 2024 | 6.591B |
| January 31, 2024 | 6.735B |
| October 31, 2023 | 6.833B |
| July 31, 2023 | 6.994B |
| April 30, 2023 | 7.04B |
| January 31, 2023 | 6.93B |
| October 31, 2022 | 6.848B |
| July 31, 2022 | 6.659B |
| April 30, 2022 | 6.527B |
| January 31, 2022 | 6.445B |
| October 31, 2021 | 6.319B |
| July 31, 2021 | 6.142B |
| April 30, 2021 | 5.817B |
| January 31, 2021 | 5.53B |
| October 31, 2020 | 5.339B |
| July 31, 2020 | 5.223B |
| April 30, 2020 | 5.236B |
| January 31, 2020 | 5.236B |
| October 31, 2019 | 5.163B |
| July 31, 2019 | 5.09B |
| April 30, 2019 | 5.019B |
| January 31, 2019 | 4.987B |
| October 31, 2018 | 4.914B |
| July 31, 2018 | 4.809B |
| Date | Value |
|---|---|
| April 30, 2018 | 4.72B |
| January 31, 2018 | 4.616B |
| October 31, 2017 | 4.472B |
| July 31, 2017 | 4.394B |
| April 30, 2017 | 4.324B |
| January 31, 2017 | 4.241B |
| October 31, 2016 | 4.202B |
| July 31, 2016 | 4.126B |
| April 30, 2016 | 4.096B |
| January 31, 2016 | 4.04B |
| October 31, 2015 | 4.038B |
| July 31, 2015 | 4.046B |
| April 30, 2015 | 4.041B |
| January 31, 2015 | 4.066B |
| October 31, 2014 | 4.048B |
| July 31, 2014 | 1.835B |
| April 30, 2014 | 2.478B |
| January 31, 2014 | 3.222B |
| October 31, 2013 | 3.894B |
| July 31, 2013 | 6.831B |
| April 30, 2013 | 6.902B |
| January 31, 2013 | 6.903B |
| October 31, 2012 | 6.858B |
| July 31, 2012 | 6.819B |
| April 30, 2012 | 6.787B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
5.223B
Minimum
Jul 2020
7.04B
Maximum
Apr 2023
6.260B
Average
6.497B
Median
Jul 2024
Revenue (TTM) Benchmarks
| Bio-Rad Laboratories Inc | 2.580B |
| Bruker Corp | 3.241B |
| Azenta Inc | 656.32M |
| Harvard Bioscience Inc | 97.73M |
| Phibro Animal Health Corp | 1.047B |